Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as postremission therapy

Journal of Clinical Oncology

Volumn 11, Issue 10, 1993, Pages 1990-2001

  Fière, Denis ^a   Lepage, Eric ^b   Sebban, Catherine ^b   Boucheix, Claude ^b   Gisselbrecht, Christian ^b   Vernant, Jean Paul ^b   Varet, Bruno ^b   Broustet, Antoine ^b   Cahn, J Y ^b   Rigal Huguet, Francoise ^b   Witz, Francis ^b   Michaux, Jean Louis ^b   Michallet, Mauricette ^b   Reiflers, Josy ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE; ZORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; GASTROINTESTINAL SYMPTOM; HLA TYPING; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZATION; REMISSION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0027436249     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.10.1990     Document Type: Article

References (25)

1. Jacobs AD, Gale RP: Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. N Engl J Med 311:1219-1231, 1984
2. Champlin R, Gale RP: Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 73:2051-2066, 1989
3. Cuttner J, Mick R, Budman DR, et al: Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: A CALGB study. Leukemia 5:425-431, 1991
4. Gaynor J, Chapman D, Little C, et al: A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: The Memorial Hospital experience since 1969. J Clin Oncol 6:1014-1030, 1988
5. Hoelzer D, Thiel E, Loffler H, et al: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123-131, 1988
6. Radford JE Jr, Burns CP, Jones MP, et al: Adult acute lymphoblastic leukemia: Results of the Iowa HOP-L protocol. J Clin Oncol 7:58-66, 1989
7. Stryckmans P, De Witte Th, Marie JP, et al: Therapy of adult ALL. Overview of 2 successive EORTC studies (ALL 2 and ALL 3). Leukemia 6:199-203, 1992 (suppl 2)
8. Mandelli F, Annino L, Vegna ML, et al: Gimena. ALL-0288: A multicentric study on adult acute lymphoblastic leukemia. Preliminary results. Leukemia 6:182-185, 1992 (suppl 2)
9. Linker CA, Levitt LJ, O'Donnell M et al: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 78:2814-2822, 1991
10. Hoelzer D, Gale RP: Acute lymphoblastic leukemia in adults. Recent progress, future directions. Semin Hematol 24:37-39, 1987
11. Gorin NC, Herve P, Aergeter P, et al: Autologous bone marrow transplantation in acute leukemia in remission. Br J Haematol 64:385-395, 1986
12. Gorin NC, Aegerter P, Auvert P, et al: Autologous bone marrow transplantation (ABMT) for acute leukemia in remission: 5th European survey. Evidence in favor of marrow purging. Influence of retransplant intervals. Bone Marrow Transplant 3:39-41, 1988 (suppl 1)
13. Kersey JH, Weisdorf D, Nesbit ME, et al: Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukemia. N Engl J Med 317:461-467, 1987
14. Santos GW, Yearger AM, Jones RJ: Autologous bone marrow transplantation. Ann Rev Med 40:99-112, 1989
15. Zwaan FE, Hermans J, Barrett AJ, et al: Bone marrow transplantation for acute lymphoblastic leukemia: A survey of the European Group for Bone Marrow Transplantation (EGBMT). Br J Maematol 58:33-42, 1984
16. Weisdorf DJ, Nesbit ME, Ramsay NKC, et al: Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: Prolonged survival associated with acute graft versus host disease. J Clin Oncol 5:1348-1355, 1987
17. Blume KG, Forman SJ, Snyder DS, et al: Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation 3:389-392, 1987
18. Doney K, Buckner CD, Kopecky KJ, et al: Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission. Bone Marrow Transplant 2:355-363, 1987
19. Fiere D, Extra JM, David B, et al: Treatment of 218 adults with acute lymphoblastic leukemias. Semin Oncol 14:64-66, 1987
20. Vernant JP, Marit G, Maraninchi D, et al: Allogenic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission. J Clin Oncol 6:227-231, 1988
21. Fiere D, Broustet A, Leblond V, et al: Comparison of chemotherapy, autologous and allogeneic transplantation as post induction regimen in adult acute lymphoblastic leukemia. A preliminary multicentric study, in Buchner T, Schellong G, Hiddeman W, et al (eds): Haematol and Blood Transfusion, Acute Leukemia II. Berlin, Germany, Springer Verlag, 1990, pp 409-412
22. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the acute leukaemias. Br J Haematol 33:451-458, 1976
23. Benjamin RS, Keating MJ, Swenerton KD, et al: Clinical studies with rubidazone. Cane Treat Rep 63:925-929, 1979
24. Arlin ZA, Feldman E, Kemmin S, et al: Amsacrine with high dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood 72:433-435, 1988
25. Thomas ED, Sanders JE, Flournoy N, et al: Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54:468-476, 1979